Johnson & Johnson, the DePuy hip replacement manufacturer, has set aside $922 million to cover litigation costs. In its fourth quarter earnings, the company said its DePuy Orthopaedics subsidiary faces a growing number of suits over its ASR hip replacements. While the amount set aside will involve this money for settlements, in our opinion it won’t be enough to satisfy all claims.
DePuy, an Indiana-based division of Johnson & Johnson, recalled the ASR hip system on August 26, 2010 after hundreds of patients complained to the Food and Drug Administration that the device failed soon after implantation. The lawsuits seek redress for severe injuries, debilitating pain, severe inflammation of surrounding tissue and bone, loss of mobility and the need for surgery to remove and replace the ASR hip implant devices. As we have previously reported, the more than 100 hip recall lawsuits were recently consolidated in the U.S. District Court for the Northern District of Ohio for pretrial proceedings.
There will be more cases filed in the near future. As we reported last month, Navan Ward, a lawyer in our Mass Torts Section, was selected for membership on the committee in charge of the MDL litigation. If you need more information on this litigation, contact Navan at 800-898-2034 or by email at Navan.Ward@beasleyallen.com.
Source: Lawyers USA Online
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.